A new article published in the Cell Reports describes how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett syndrome in preclinical models. The study was led by Dr. Manel Esteller, ...
May 15, 2018
0
3
An article published in Nature Medicine shows that the inheritance of small changes in DNA alters the expression of the PM20D1 gene and is associated with an increased risk of developing Alzheimer's disease.
May 15, 2018
0
12
A research collaboration has led to a new potential treatment for hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler syndrome, a rare disease that affects blood vessels and was previously untreatable. The study, published ...
Apr 27, 2018
0
1
The sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most frequent bone cancer ...
Apr 6, 2018
0
3
Researchers of the Sarcoma group at Bellvitge Biomedical Research Institute have successfully tested a new combined therapy for the treatment of sarcoma, a rare, aggressive tumor type affecting children and adults. The results ...
Jan 17, 2018
0
40
Researchers at Bellvitge Biomedical Research Institute have described a key cellular receptor in the processes of metastasis in ovarian cancer. The finding, published in Molecular Cancer Therapeutics, might lead to the use ...
Jan 5, 2018
0
2
A new study carried out by the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Global Health of Barcelona (ISGlobal) associates first-time mild obsessive-compulsive symptoms to characteristics and specific ...
Dec 20, 2017
0
3
A study led by the Bellvitge Biomedical Research Institute (IDIBELL) has identified a neural mechanism that allows humans to segment experience into discrete memory units. According to the research, published in the scientific ...
Nov 28, 2017
0
13
IDIBELL Researchers of the Neuro-Oncology Unit of Bellvitge University Hospital - Catalan Institute of Oncology, led by Dr. Jordi Bruna, have successfully tested a new molecule capable of preventing the development of peripheral ...
Oct 24, 2017
0
1
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have found a new genetic marker that would explain up to 1.4 percent of inherited colon cancer cases not related to mutations currently associated with ...
Oct 11, 2017
0
2
